Invivyd Inc. (IVVD)

Invivyd Inc. (IVVD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $182M; returns 1 day +0.5%, 1 week -0.8%, 1 year -68.4%.

Invivyd Inc. (IVVD) is a commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing antibody-based solutions for infectious diseases, primarily targeting SARS-CoV-2. The company's proprietary INVYMAB platform combines viral surveillance, predictive modeling, and advanced antibody engineering to generate new monoclonal antibodies (mAbs).

Groups IVVD belongs to

• Biotechnology
• Biopharmaceutical
• Commercial Stage Biotech
• Infectious Diseases
• Monoclonal Antibodies
• Antibody Therapeutics
• COVID-19
• Healthcare
• Clinical Stage Biopharma
• Life Sciences
• Fast Track Designation

IVVD financial model: income statement, cash flow and balance sheet